Cargando…
Kidney Function Change and All-Cause Mortality in Denosumab Users with and without Chronic Kidney Disease
Denosumab is approved for osteoporosis treatment in subjects with and without chronic kidney disease (CKD). Confirmation is required for its safety, treatment adherence, renal function effect, and mortality in patients with CKD. A retrospective cohort study was conducted to compare new users of deno...
Autores principales: | Wu, Ping-Hsun, Lin, Ming-Yen, Huang, Teng-Hui, Lee, Tien-Ching, Lin, Sung-Yen, Chen, Chung-Hwan, Kuo, Mei-Chuan, Chiu, Yi-Wen, Chang, Jer-Ming, Hwang, Shang-Jyh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875658/ https://www.ncbi.nlm.nih.gov/pubmed/35207673 http://dx.doi.org/10.3390/jpm12020185 |
Ejemplares similares
-
U-Shaped Association between Waist-to-Hip Ratio and All-Cause Mortality in Stage 3–5 Chronic Kidney Disease Patients with Body Mass Index Paradox
por: Shen, Feng-Ching, et al.
Publicado: (2021) -
Association of Angiopoietin-2 with Renal Outcome in Chronic Kidney Disease
por: Tsai, Yi-Chun, et al.
Publicado: (2014) -
Association of digoxin with mortality in patients with advanced chronic kidney disease: A population-based cohort study
por: Yang, Lii-Jia, et al.
Publicado: (2021) -
Hyperuricemia, a Non-Independent Component of Metabolic Syndrome, Only Predicts Renal Outcome in Chronic Kidney Disease Patients without Metabolic Syndrome or Diabetes
por: Niu, Sheng-Wen, et al.
Publicado: (2022) -
Variability in Estimated Glomerular Filtration Rate by Area under the Curve Predicts Renal Outcomes in Chronic Kidney Disease
por: Chen, Szu-Chia, et al.
Publicado: (2014)